Elanco Animal Health Reports Second Quarter 2025 Results

Organic CC Growth = Represents revenue growth excluding the impacts from our prior year divestiture of the aqua business, which was divested July 9, 2024, royalty revenue that was sold to a third ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines ... Read More

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

I rate Elanco Animal Health Incorporated shares a Buy with a $20 fair value, driven by strong innovation and recent operational improvements. Elanco's focus on innovative products like Zenrelia and ... Read More

Elanco (ELAN) Q2 Revenue Jumps 5%

GAAP revenue surpassed estimates at $1,241 million in Q2 2025, up 5.0% year over year, driven by innovation-led gains in pet and farm animal health. Adjusted EPS of $0.26 beat analyst expectations by ... Read More

Elanco raises 2025 innovation revenue outlook to $720M–$800M, signals margin expansion through new launches

CEO Jeffrey N. Simmons highlighted, "Elanco continues to deliver, growing 8% organic constant currency in the quarter and exceeding the high end of guidance for revenue, adjusted EBITDA and adjusted ... Read More

Elanco Swings to 2Q Profit, Boosts 2025 Adj EPS, Rev View on Demand, Forex

Elanco Animal Health swung to a second-quarter profit, and the maker of pet medicine boosted its revenue and adjusted earnings projections for the year, as resilient demand and foreign-exchange ... Read More

Elanco reports pet parasite treatment quickly hit $100M blockbuster status

The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis. Read More

Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost

We recently published 10 Hot Stocks Making Winning Look Easy. Elanco Animal Health Inc. (NYSE:ELAN) is one of the best-performing stocks on Thursday. Elanco saw its share prices surge to a new 52-week ... Read More

Elanco Animal Health Reports Second Quarter 2025 Results

Adjusted EPS is calculated as the sum of reported EPS and total adjustments to EPS. Reconciliation of 2025 third quarter reported net loss to 2025 third quarter adjusted EBITDA guidance is as follows: ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year. Despite the decline, earnings ... Read More